Immunogenicity (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Immunogenicity" in English language version.

refsWebsite

Global rank English rank

23nih.gov

4^th place

17doi.org

2^nd place

3semanticscholar.org

11^th place

8^th place

1whiterose.ac.uk

4,124^th place

2,320^th place

1handle.net

102^nd place

76^th place

1worldcat.org

5^th place

1books.google.com

3^rd place

1uri.edu

8,176^th place

5,290^th place

books.google.com

Fishman, Jonathan M.; Wiles, Katherine; Wood, Kathryn J. (2015). "The Acquired Immune System Response to Biomaterials, Including Both Naturally Occurring and Synthetic Biomaterials". In Badylak, Stephen F. (ed.). Host Response to Biomaterials. Academic Press. pp. 151–187. doi:10.1016/B978-0-12-800196-7.00008-6. ISBN 978-0-12-800196-7.

doi.org

Leroux-Roels, Geert; Bonanni, Paolo; Tantawichien, Terapong; Zepp, Fred (August 2011). "Vaccine development". Perspectives in Vaccinology. 1 (1): 115–150. doi:10.1016/j.pervac.2011.05.005.
De Groot, Anne S.; Scott, David W. (November 2007). "Immunogenicity of protein therapeutics". Trends in Immunology. 28 (11): 482–490. doi:10.1016/j.it.2007.07.011. PMID 17964218.
Baker, Matthew; Reynolds, Helen M.; Lumicisi, Brooke; Bryson, Christine J. (October 2010). "Immunogenicity of protein therapeutics: The key causes, consequences and challenges". Self/Nonself. 1 (4): 314–322. doi:10.4161/self.1.4.13904. PMC 3062386. PMID 21487506.
Lindsey, Benjamin B; Armitage, Edwin P; Kampmann, Beate; de Silva, Thushan I (April 2019). "The efficacy, effectiveness, and immunogenicity of influenza vaccines in Africa: a systematic review" (PDF). The Lancet Infectious Diseases. 19 (4): e110–e119. doi:10.1016/S1473-3099(18)30490-0. hdl:10044/1/65398. PMID 30553695. S2CID 58767762.
Nic Lochlainn, Laura M; de Gier, Brechje; van der Maas, Nicoline; Strebel, Peter M; Goodman, Tracey; van Binnendijk, Rob S; de Melker, Hester E; Hahné, Susan J M (November 2019). "Immunogenicity, effectiveness, and safety of measles vaccination in infants younger than 9 months: a systematic review and meta-analysis". The Lancet Infectious Diseases. 19 (11): 1235–1245. doi:10.1016/S1473-3099(19)30395-0. PMC 6838664. PMID 31548079.
Samson, Sandrine I.; Leventhal, Phillip S.; Salamand, Camille; Meng, Ya; Seet, Bruce T.; Landolfi, Victoria; Greenberg, David; Hollingsworth, Rosalind (4 March 2019). "Immunogenicity of high-dose trivalent inactivated influenza vaccine: a systematic review and meta-analysis". Expert Review of Vaccines. 18 (3): 295–308. doi:10.1080/14760584.2019.1575734. PMID 30689467. S2CID 59338782.
Dowds, C. Marie; Kornell, Sabin-Christin; Blumberg, Richard S.; Zeissig, Sebastian (1 January 2014). "Lipid antigens in immunity". Biological Chemistry. 395 (1): 61–81. doi:10.1515/hsz-2013-0220. PMC 4128234. PMID 23999493.
Stephen, Tom Li; Groneck, Laura; Kalka-Moll, Wiltrud Maria (2010). "The Modulation of Adaptive Immune Responses by Bacterial Zwitterionic Polysaccharides". International Journal of Microbiology. 2010: 917075. doi:10.1155/2010/917075. PMC 3017905. PMID 21234388.
Fishman, Jonathan M.; Wiles, Katherine; Wood, Kathryn J. (2015). "The Acquired Immune System Response to Biomaterials, Including Both Naturally Occurring and Synthetic Biomaterials". In Badylak, Stephen F. (ed.). Host Response to Biomaterials. Academic Press. pp. 151–187. doi:10.1016/B978-0-12-800196-7.00008-6. ISBN 978-0-12-800196-7.
Weber, Constanze A.; Mehta, Preema J.; Ardito, Matt; Moise, Lenny; Martin, Bill; De Groot, Anne S. (30 September 2009). "T cell epitope: Friend or Foe? Immunogenicity of biologics in context". Advanced Drug Delivery Reviews. 61 (11): 965–976. doi:10.1016/j.addr.2009.07.001. PMC 7103283. PMID 19619593.
Singh, Surjit; Kumar, Nitish K.; Dwiwedi, Pradeep; Charan, Jaykaran; Kaur, Rimplejeet; Sidhu, Preeti; Chugh, Vinay K. (9 October 2018). "Monoclonal Antibodies: A Review". Current Clinical Pharmacology. 13 (2): 85–99. doi:10.2174/1574884712666170809124728. PMID 28799485. S2CID 27211386.
Schnyder, Benno; Pichler, Werner J. (2009). "Mechanisms of Drug-Induced Allergy". Mayo Clinic Proceedings. 84 (3): 268–272. doi:10.4065/84.3.268. PMC 2664605. PMID 19252115.
Doevendans, Erik; Schellekens, Huub (5 March 2019). "Immunogenicity of Innovative and Biosimilar Monoclonal Antibodies". Antibodies. 8 (1): 21. doi:10.3390/antib8010021. PMC 6640699. PMID 31544827.
Stryjewska, Agnieszka; Kiepura, Katarzyna; Librowski, Tadeusz; Lochyński, Stanisław (September 2013). "Biotechnology and genetic engineering in the new drug development. Part II. Monoclonal antibodies, modern vaccines and gene therapy". Pharmacological Reports. 65 (5): 1086–1101. doi:10.1016/s1734-1140(13)71467-1. PMID 24399705.
Lonberg, Nils; Huszar, Dennis (January 1995). "Human Antibodies from Transgenic Mice". International Reviews of Immunology. 13 (1): 65–93. doi:10.3109/08830189509061738. PMID 7494109.
Pecoraro, Valentina; De Santis, Elena; Melegari, Alessandra; Trenti, Tommaso (June 2017). "The impact of immunogenicity of TNFα inhibitors in autoimmune inflammatory disease. A systematic review and meta-analysis". Autoimmunity Reviews. 16 (6): 564–575. doi:10.1016/j.autrev.2017.04.002. PMID 28411169.
Kuriakose, Anshu; Chirmule, Narendra; Nair, Pradip (2016). "Immunogenicity of Biotherapeutics: Causes and Association with Posttranslational Modifications". Journal of Immunology Research. 2016: 1–18. doi:10.1155/2016/1298473. PMC 4942633. PMID 27437405.

handle.net

hdl.handle.net

Lindsey, Benjamin B; Armitage, Edwin P; Kampmann, Beate; de Silva, Thushan I (April 2019). "The efficacy, effectiveness, and immunogenicity of influenza vaccines in Africa: a systematic review" (PDF). The Lancet Infectious Diseases. 19 (4): e110–e119. doi:10.1016/S1473-3099(18)30490-0. hdl:10044/1/65398. PMID 30553695. S2CID 58767762.

nih.gov

pubmed.ncbi.nlm.nih.gov

De Groot, Anne S.; Scott, David W. (November 2007). "Immunogenicity of protein therapeutics". Trends in Immunology. 28 (11): 482–490. doi:10.1016/j.it.2007.07.011. PMID 17964218.
Baker, Matthew; Reynolds, Helen M.; Lumicisi, Brooke; Bryson, Christine J. (October 2010). "Immunogenicity of protein therapeutics: The key causes, consequences and challenges". Self/Nonself. 1 (4): 314–322. doi:10.4161/self.1.4.13904. PMC 3062386. PMID 21487506.
Lindsey, Benjamin B; Armitage, Edwin P; Kampmann, Beate; de Silva, Thushan I (April 2019). "The efficacy, effectiveness, and immunogenicity of influenza vaccines in Africa: a systematic review" (PDF). The Lancet Infectious Diseases. 19 (4): e110–e119. doi:10.1016/S1473-3099(18)30490-0. hdl:10044/1/65398. PMID 30553695. S2CID 58767762.
Nic Lochlainn, Laura M; de Gier, Brechje; van der Maas, Nicoline; Strebel, Peter M; Goodman, Tracey; van Binnendijk, Rob S; de Melker, Hester E; Hahné, Susan J M (November 2019). "Immunogenicity, effectiveness, and safety of measles vaccination in infants younger than 9 months: a systematic review and meta-analysis". The Lancet Infectious Diseases. 19 (11): 1235–1245. doi:10.1016/S1473-3099(19)30395-0. PMC 6838664. PMID 31548079.
Samson, Sandrine I.; Leventhal, Phillip S.; Salamand, Camille; Meng, Ya; Seet, Bruce T.; Landolfi, Victoria; Greenberg, David; Hollingsworth, Rosalind (4 March 2019). "Immunogenicity of high-dose trivalent inactivated influenza vaccine: a systematic review and meta-analysis". Expert Review of Vaccines. 18 (3): 295–308. doi:10.1080/14760584.2019.1575734. PMID 30689467. S2CID 59338782.
Dowds, C. Marie; Kornell, Sabin-Christin; Blumberg, Richard S.; Zeissig, Sebastian (1 January 2014). "Lipid antigens in immunity". Biological Chemistry. 395 (1): 61–81. doi:10.1515/hsz-2013-0220. PMC 4128234. PMID 23999493.
Stephen, Tom Li; Groneck, Laura; Kalka-Moll, Wiltrud Maria (2010). "The Modulation of Adaptive Immune Responses by Bacterial Zwitterionic Polysaccharides". International Journal of Microbiology. 2010: 917075. doi:10.1155/2010/917075. PMC 3017905. PMID 21234388.
Weber, Constanze A.; Mehta, Preema J.; Ardito, Matt; Moise, Lenny; Martin, Bill; De Groot, Anne S. (30 September 2009). "T cell epitope: Friend or Foe? Immunogenicity of biologics in context". Advanced Drug Delivery Reviews. 61 (11): 965–976. doi:10.1016/j.addr.2009.07.001. PMC 7103283. PMID 19619593.
Singh, Surjit; Kumar, Nitish K.; Dwiwedi, Pradeep; Charan, Jaykaran; Kaur, Rimplejeet; Sidhu, Preeti; Chugh, Vinay K. (9 October 2018). "Monoclonal Antibodies: A Review". Current Clinical Pharmacology. 13 (2): 85–99. doi:10.2174/1574884712666170809124728. PMID 28799485. S2CID 27211386.
Schnyder, Benno; Pichler, Werner J. (2009). "Mechanisms of Drug-Induced Allergy". Mayo Clinic Proceedings. 84 (3): 268–272. doi:10.4065/84.3.268. PMC 2664605. PMID 19252115.
Doevendans, Erik; Schellekens, Huub (5 March 2019). "Immunogenicity of Innovative and Biosimilar Monoclonal Antibodies". Antibodies. 8 (1): 21. doi:10.3390/antib8010021. PMC 6640699. PMID 31544827.
Stryjewska, Agnieszka; Kiepura, Katarzyna; Librowski, Tadeusz; Lochyński, Stanisław (September 2013). "Biotechnology and genetic engineering in the new drug development. Part II. Monoclonal antibodies, modern vaccines and gene therapy". Pharmacological Reports. 65 (5): 1086–1101. doi:10.1016/s1734-1140(13)71467-1. PMID 24399705.
Lonberg, Nils; Huszar, Dennis (January 1995). "Human Antibodies from Transgenic Mice". International Reviews of Immunology. 13 (1): 65–93. doi:10.3109/08830189509061738. PMID 7494109.
Pecoraro, Valentina; De Santis, Elena; Melegari, Alessandra; Trenti, Tommaso (June 2017). "The impact of immunogenicity of TNFα inhibitors in autoimmune inflammatory disease. A systematic review and meta-analysis". Autoimmunity Reviews. 16 (6): 564–575. doi:10.1016/j.autrev.2017.04.002. PMID 28411169.
Kuriakose, Anshu; Chirmule, Narendra; Nair, Pradip (2016). "Immunogenicity of Biotherapeutics: Causes and Association with Posttranslational Modifications". Journal of Immunology Research. 2016: 1–18. doi:10.1155/2016/1298473. PMC 4942633. PMID 27437405.

ncbi.nlm.nih.gov

Baker, Matthew; Reynolds, Helen M.; Lumicisi, Brooke; Bryson, Christine J. (October 2010). "Immunogenicity of protein therapeutics: The key causes, consequences and challenges". Self/Nonself. 1 (4): 314–322. doi:10.4161/self.1.4.13904. PMC 3062386. PMID 21487506.
Nic Lochlainn, Laura M; de Gier, Brechje; van der Maas, Nicoline; Strebel, Peter M; Goodman, Tracey; van Binnendijk, Rob S; de Melker, Hester E; Hahné, Susan J M (November 2019). "Immunogenicity, effectiveness, and safety of measles vaccination in infants younger than 9 months: a systematic review and meta-analysis". The Lancet Infectious Diseases. 19 (11): 1235–1245. doi:10.1016/S1473-3099(19)30395-0. PMC 6838664. PMID 31548079.
Dowds, C. Marie; Kornell, Sabin-Christin; Blumberg, Richard S.; Zeissig, Sebastian (1 January 2014). "Lipid antigens in immunity". Biological Chemistry. 395 (1): 61–81. doi:10.1515/hsz-2013-0220. PMC 4128234. PMID 23999493.
Stephen, Tom Li; Groneck, Laura; Kalka-Moll, Wiltrud Maria (2010). "The Modulation of Adaptive Immune Responses by Bacterial Zwitterionic Polysaccharides". International Journal of Microbiology. 2010: 917075. doi:10.1155/2010/917075. PMC 3017905. PMID 21234388.
Weber, Constanze A.; Mehta, Preema J.; Ardito, Matt; Moise, Lenny; Martin, Bill; De Groot, Anne S. (30 September 2009). "T cell epitope: Friend or Foe? Immunogenicity of biologics in context". Advanced Drug Delivery Reviews. 61 (11): 965–976. doi:10.1016/j.addr.2009.07.001. PMC 7103283. PMID 19619593.
Schnyder, Benno; Pichler, Werner J. (2009). "Mechanisms of Drug-Induced Allergy". Mayo Clinic Proceedings. 84 (3): 268–272. doi:10.4065/84.3.268. PMC 2664605. PMID 19252115.
Doevendans, Erik; Schellekens, Huub (5 March 2019). "Immunogenicity of Innovative and Biosimilar Monoclonal Antibodies". Antibodies. 8 (1): 21. doi:10.3390/antib8010021. PMC 6640699. PMID 31544827.
Kuriakose, Anshu; Chirmule, Narendra; Nair, Pradip (2016). "Immunogenicity of Biotherapeutics: Causes and Association with Posttranslational Modifications". Journal of Immunology Research. 2016: 1–18. doi:10.1155/2016/1298473. PMC 4942633. PMID 27437405.

semanticscholar.org

api.semanticscholar.org

Lindsey, Benjamin B; Armitage, Edwin P; Kampmann, Beate; de Silva, Thushan I (April 2019). "The efficacy, effectiveness, and immunogenicity of influenza vaccines in Africa: a systematic review" (PDF). The Lancet Infectious Diseases. 19 (4): e110–e119. doi:10.1016/S1473-3099(18)30490-0. hdl:10044/1/65398. PMID 30553695. S2CID 58767762.
Samson, Sandrine I.; Leventhal, Phillip S.; Salamand, Camille; Meng, Ya; Seet, Bruce T.; Landolfi, Victoria; Greenberg, David; Hollingsworth, Rosalind (4 March 2019). "Immunogenicity of high-dose trivalent inactivated influenza vaccine: a systematic review and meta-analysis". Expert Review of Vaccines. 18 (3): 295–308. doi:10.1080/14760584.2019.1575734. PMID 30689467. S2CID 59338782.
Singh, Surjit; Kumar, Nitish K.; Dwiwedi, Pradeep; Charan, Jaykaran; Kaur, Rimplejeet; Sidhu, Preeti; Chugh, Vinay K. (9 October 2018). "Monoclonal Antibodies: A Review". Current Clinical Pharmacology. 13 (2): 85–99. doi:10.2174/1574884712666170809124728. PMID 28799485. S2CID 27211386.

uri.edu

digitalcommons.uri.edu

Weber, Constanze A.; Mehta, Preema J.; Ardito, Matt; Moise, Lenny; Martin, Bill; De Groot, Anne S. (30 September 2009). "T cell epitope: Friend or Foe? Immunogenicity of biologics in context". Advanced Drug Delivery Reviews. 61 (11): 965–976. doi:10.1016/j.addr.2009.07.001. PMC 7103283. PMID 19619593.

whiterose.ac.uk

eprints.whiterose.ac.uk

Lindsey, Benjamin B; Armitage, Edwin P; Kampmann, Beate; de Silva, Thushan I (April 2019). "The efficacy, effectiveness, and immunogenicity of influenza vaccines in Africa: a systematic review" (PDF). The Lancet Infectious Diseases. 19 (4): e110–e119. doi:10.1016/S1473-3099(18)30490-0. hdl:10044/1/65398. PMID 30553695. S2CID 58767762.

worldcat.org

WHO (2014). WHO Expert Committee on Biological Standardization. World Health Organization. ISBN 978-92-4-069262-6. OCLC 888748977.^{[page needed]}